Elizabeth Parrish is the CEO of BioViva, a biotech company in the Seattle area that is focused on developing gene therapies that may one day mitigate the diseases of aging. She also notably is patient zero for BioViva’s groundbreaking gene therapies.
Dr. Jeffrey Bland has been an internationally recognized leader in the nutritional medicine field for over 25 years. Dr. Bland founded HealthComm International, Inc. in 1984, and served as its Chief Executive Officer until a merger with its strategic partner, Metagenics, in 2000. Dr. Bland served as Chief Science Officer for Metagenics and President of MetaProteomics for 12 years. In 2012, Dr. Bland formed a nonprofit organization called the Personalized Lifestyle Medicine Institute (PLMI) based in Seattle, Washington. More information about the PLMI can be found at www.plminstitute.org.
A nutritional biochemist and registered clinical laboratory director, Dr. Bland is a former professor of biochemistry at the University of Puget Sound, and a previous Director of Nutritional Research at the Linus Pauling Institute of Science and Medicine.